Bulletin Updates
Rossari’s growth is volume-led, but margins face raw material pressure – 5 May 2026
May 05, 2026
Rossari Biotech delivered its highest quarterly revenue and EBITDA.
But raw material spikes and softer domestic demand kept margins under watch
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »